• 1
    Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92: 3948.
  • 2
    Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care 2004; 27: 28132818.
  • 3
    Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM. Vitamin D deficiency is more common in Type 2 than in Type 1 diabetes. Diabetes Care 2006; 29: 174.
  • 4
    Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94: 483492.
  • 5
    Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8: 894901.
  • 6
    Duprez D, De Buyzere M, De Backer T, Clement D. Relationship between vitamin D and the regional blood flow and vascular resistance in moderate arterial hypertension. J Hypertens 1993; 11: S304S305.
  • 7
    Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, Type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005; 98: 10241027.
  • 8
    Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R et al . Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 17551760.
  • 9
    Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of short term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone level in elderly women. J Clin Endocrinol Metab 2001; 86: 16331637.
  • 10
    Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352: 709710.
  • 11
    Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in Type 2 diabetic patients. Int J Clin Pract 2003; 57: 258261.
  • 12
    Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr 1998; 79: 315327.
  • 13
    Widlansky ME, Gokce N, Keaney JF Jr, Vita J. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 11491160.
  • 14
    Davies JI, Band M, Morris A, Struthers AD. Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes. Diabetologia 2004; 47: 16871694.
  • 15
    Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109 s1: IV36IV41.
  • 16
    Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39: 257265.
  • 17
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 18
    Vita JA, Keaney JF. Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 106: 640642.
  • 19
    Li Y, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin  D3 is a negative endocrine regulator of the rennin–angiotensin system. J Clin Invest 2002; 110: 229238.
  • 20
    Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 2005; 25: 3946.
  • 21
    Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754759.
  • 22
    Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Fried J et al . Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361370.
  • 23
    Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC et al . Synthesis of 1,25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine derteminant of vascular cell adhesion. J Am Soc Nephrol 2002; 13: 621629.
  • 24
    Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M et al . Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of Type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol 2005; 46: 827834.
  • 25
    Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T et al . Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 2006; 99: 715722.
  • 26
    Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among Type 2 diabetic patients. Diabetes Care 2006; 29: 722724.
  • 27
    Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40: 344347.
  • 28
    Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005; 48: 12471257.
  • 29
    Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P et al . Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846854.
  • 30
    Francis RM, Anderson FH, Patel S, Sahota O, Van Staa TP. Calcium and vitamin D in the prevention of osteoporotic fractures. Quart J Med 2006; 99: 355363.